Premium
Twelve‐year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early‐stage breast carcinoma patients (SITAM 01)
Author(s) -
Alliot Carol
Publication year - 2006
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.21960
Subject(s) - medicine , tamoxifen , mastectomy , radiation therapy , randomized controlled trial , stage (stratigraphy) , breast cancer , adjuvant therapy , adverse effect , hormonal therapy , adjuvant , oncology , lymph node , chemotherapy , surgery , gynecology , cancer , biology , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom